跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SOLIFENACIN VIATRIS solifenacin succinate 5 mg tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
SOLIFENACIN VIATRIS solifenacin succinate 5 mg tablet bottle
Approved
STANDARD
SOLIFENACIN VIATRIS solifenacin succinate 5 mg tablet bottle
Alphapharm Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
d54306140009b33e
Company
Alphapharm Pty Ltd
Type
Standard
Approval Details
Approval Id
d54306140009b33e
Product Name
SOLIFENACIN VIATRIS solifenacin succinate 5 mg tablet bottle
Artg Id
268512
Artg Name
SOLIFENACIN VIATRIS solifenacin succinate 5 mg tablet bottle
Sponsor
Alphapharm Pty Ltd
Company Detail Path
/organization/alphapharm-pty-ltd
Artg Date
2020-03-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b2ccab3b4b5b77e821c9726e06e8d09f.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/3cd74170a7fdcbb8a301b57df2c04e6c.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
d54306140009b33e
Type
Standard
Back to TGA Approvals